Autologous hematopoietic stem cell transplantation (aHSCT) is increasingly recognized as a potential therapy for patients with highly active multiple sclerosis (MS). This study (doi:10.1002/acn3.51366 ) aims to assess outcome differences in disease activity in MS patients treated either with aHSCT or alemtuzumab.
To evaluate the impact of the Coronavirus disease of 2019 (COVID‐19) pandemic on patients with migraine a study was designed and recently published: Haghdoost, F., Carcel, C., Chandrasekhar, D. et al. The impact of Coronavirus disease 2019 (COVID‐19) pandemic on migraine disorder. J Neurol (2021). https://doi.org/10.1007/s00415-021-10590-x
Migraine is three times more common in women.
Exercise might help prevent cognitive decline in high-risk patients with early Parkinson's disease (PD), new research suggests.
The number of demyelinating diseases of central nervous system are prone to grow nowadays. The most socially significant and well studied one is multiple sclerosis.
A minimally invasive blood test along with artificial intelligence (AI) may flag early-stage Alzheimer's disease (AD), raising the prospect of early intervention when effective treatments become available.
As more patients gain access to the coronavirus disease - 2019 (COVID-19) vaccines, neurologists are facing questions about potential neurological complications, benefits, and timing of vaccination.
Maintaining a healthy plant-based diet is associated with a lower risk for both total stroke and ischemic stroke, results from a study of three large cohorts suggest.
New analyses of both observational and genetic data have provided "convincing evidence" that type 2 diabetes is associated with an increased risk for Parkinson's disease.
Donanemab slowed cognitive decline by 32% on the Integrated AD Rating Scale (iADRS) from baseline to 76 weeks relative to placebo.
